Quantcast

Latest hyperglycemia Stories

2010-12-22 12:05:00

ALAMEDA, Calif., Dec. 22, 2010 /PRNewswire/ -- Abbott Diabetes Care today announced that it has initiated a recall of 359 lots (approximately 359 million strips) of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium(TM), Optium(TM), OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico. The test strips are used with Abbott's Precision Xtra, Precision Xceed Pro, MediSense...

2010-09-21 06:30:00

BRIDGEWATER, N.J., Sept. 21 /PRNewswire/ -- Actor Paul Sorvino, living with type 2 diabetes, and his daughter, Academy-award winning actress Mira Sorvino, have teamed up with sanofi-aventis U.S. to launch "Diabetes Co-Stars," an awareness program aimed to help people living with diabetes and those who support them. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/sanofi-aventis/45550/ "'Diabetes Co-Stars' will help inspire...

2010-09-20 23:16:14

High blood glucose levels after surgery may be an important risk factor for infection at the surgical site in patients having general surgery, according to a report in the September issue of Archives of Surgery, one of the JAMA/Archives journals. Surgical site infection accounts for 14 percent to 17 percent of hospital-acquired infections, making it the third most common type of infection acquired at health-care facilities and the most common among patients having surgery, according to...

2010-09-20 04:58:00

STOCKHOLM, September 20, 2010 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY)(http://www.bms.com) and AstraZeneca (NYSE: AZN)(http://www.astrazeneca-us.com) today announced results from a randomized, double blind Phase 3 clinical study, which demonstrated that the addition of the investigational drug dapagliflozin to existing glimepiride (sulphonylurea) therapy produced significant reductions in glycosylated hemoglobin levels (HbA1c) in adult patients with type 2...

2010-07-15 14:25:59

Research finds Type 1 diabetes affects athletic performance, but can be managed A new study led by York University researchers finds that young athletes with Type 1 diabetes may experience a marked decrease in performance as a result of their blood sugar levels. The study, published in the International Journal of Pediatrics, reports that participants' athletic prowess was sapped by low blood glucose, a condition known as hypoglycemia. Their cognitive abilities also declined as a result....

2010-07-14 08:00:00

YINCHUAN, China, July 14 /PRNewswire-Asia/ -- Recently, Xinhua Website reported about Dr. Nie Wentao's nutrition intervention technology for type 1 diabetes mellitus. Dr. Nie Wentao's diabetic treatment technology is becoming a mainstream technology for diabetes treatment, so it aroused widespread concern in China. Dr. Nie Wentao, having engaged in the study of nutrition interventions on diabetes mellitus for a long period, has great influence in the field of diabetes treatment in China....

2010-07-08 12:43:16

Hyperglycemia during critical illness may be used as a warning of future diabetes. Researchers writing in BioMed Central's open access journal Critical Care have found a significant association between acute illness complicated with hyperglycaemia and the future development of type II diabetes or glucose intolerance. Ivan Gornik worked with a team of researchers from University Hospital Centre Rebro, Croatia, to follow patients for 5 years after they were discharged from the hospital. There...

2010-06-30 14:33:56

Lead author of Lancet paper from clinical site University Hospitals Case Medical Center In an analysis from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, one of the largest studies of its kind to determine whether intensive blood glucose (sugar) control worked better than standard blood sugar control among diabetics, results show that the benefits of intensive therapy need to be balanced against the increase in total and cardiovascular disease-related death, increased...

2010-06-29 03:05:46

Eleven years after the introduction of the diabetes drug rosiglitazone, data from available clinical trials demonstrate an increased risk for heart attack associated with its use and suggest an unfavorable benefit-to-risk ratio, according to a report posted online today that will appear in the July 26 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals. The study was published online in advance of an upcoming Food and Drug Administration meeting that will review...

2010-06-27 11:00:00

SAN DIEGO, June 27 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) today announced Phase 2 results demonstrating that the subcutaneous coinjection of rHuPH20 (recombinant human hyaluronidase, PH20) with lispro significantly improves postprandial hyperglycemia, reduces hypoglycemia, and accelerates the absorption of mealtime insulin in patients with type 2 diabetes. Significantly more patients receiving lispro+PH20, 71% versus 48%, achieved the American Diabetes...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related